Locations:

Tumor Oncology

November 23, 2020/Cancer/Tumor Oncology

Case Report: Immunotherapy + Vaccine Helps 62-Year-Old with Colorectal Cancer

Nivolumab, CV301 and systemic chemotherapy trial

November 19, 2020/Cancer/Tumor Oncology

Case Report: 58-Year-Old Woman with Neuroendocrine Carcinoma of the Cervix

Treatment based on next generation sequencing shows promise

November 13, 2020/Cancer/Tumor Oncology

Global Trial Seeks New Gold Standard Treatment for HER2+ Early Breast Cancer in Post-Neoadjuvant Setting

New drug among the most potent antibody-drug conjugates in development

November 10, 2020/Cancer/Tumor Oncology

Case Report: 46-Year-Old with Metastatic Papillary Thyroid Cancer

During global health crisis, investigational drug proves successful

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

October 8, 2020/Cancer/Tumor Oncology

FDA Approves New Treatment Regime for Advanced Liver Cancer

IMbrave-150 changes standard of care

September 17, 2020/Cancer/Tumor Oncology

A New Option for Patients with RET Fusion-Positive NSCLC Demonstrates Safety and Efficacy

Selpercatinib beats others in ORR, PFS, safety

June 3, 2019/Cancer/Tumor Oncology

Rivaroxaban Reduces VTE in Patients with Pancreatic Cancer

Add prophylaxis for patients receiving systemic therapy

April 12, 2019/Cancer/Tumor Oncology

Metastatic Non-Clear Cell Renal Cancer Patients Have Positive Response to Immunotherapy

Analysis provides evidence to guide treatment of uncommon RCC subtypes

March 12, 2019/Cancer/Tumor Oncology

Three Treatment Modalities Emerge for Patients with Triple-Negative Breast Cancer

Immunotherapy, PARP inhibitors and a targeted therapy

March 4, 2019/Cancer/Tumor Oncology

More Therapies to Consider for Advanced and Refractory Renal Cell Carcinoma

Results of two studies presented at 2019 ASCO GU

BackPage 2 of 3Next